Genetic analyses ofmonoplasmic and heteroplasmic hybrid cells showed that Mlfl and MY, were mitochondrial genes and could be expressed codominantly (24, 27) . More recently, we showed that Mtf peptides were mitochondrially encoded and had unusually short half-lives (28); we suggested that Mtf encodes a signal peptide derived during maturation of respiratory enzymes . Indeed, Wang et al. (29) reported that a peptide from the NH2 terminus of a 35-kD subunit of the mitochondrial NADH dehydrogenase (NDI) behaved in CML assays as an Mtf gene product . In addition, they found that the different Mtf alleles are created by substitution in codon 6 of NHl, which in the Mtf alleles a, 0, -f, and 6 encodes isoleucine, alanine, valine, and threonine, respectively.
Mta has the characteristics ofan MHC class I molecule that functions in presentation ofa selfpeptide at the surface ofcells in some unique fashion . This phenomenon of self peptide presentation is seen on mouse cells of diverse tissue origin (24) . The general phenomenon of binding and presentation of self peptides by MHC molecules was proposed more than 10 years ago (30) and was demonstrated more recently for class II molecules in vitro (31) (32) (33) and in vivo (34, 35) . Lorenz and Allen (34) suggested that constitutive processing and presentation ofselfantigens has potentially far-reaching significance in self-tolerance, autoimmunity, and alloreactivity.
Mta is an immunological mystery. On one hand, Hmt, which belongs to a group of"nonclassical" MHC class I molecules that are not known to be antigen-presenting molecules, restricts T cell recognition of Mtf peptides. On the other, Mtf peptides are not restricted by the H-2K/D/L antigen-presenting molecules, which are the restriction elements of all other defined conventional antigens (20) . To account for this unusual pattern of Mta T cell recognition, we postulated that the Hint gene product would have a special chemical affinity for Mtf peptides (20) . In addition, Mtf peptides should have distinct biochemical properties that prevent or limit their ability to be restricted by H-2K/D/L antigen-presenting molecules . Because prokaryotic and mitochondrial ribosomes, but not cytoplasmic ribosomes, initiate proteins with N-formyl-methionine (36), we hypothesized that the N-formyl group on mitochondrial peptides might provide the requisite chemical tag (20) . We sought to test our model by asking whether the N-formyl group was required for synthetic Mtf peptide activity, and whether this moiety was recognized by specific antigen-presenting molecules on target cells .
Materials and Methods
Mice. Fl mice of (NZB Q x BALB/c a'; Mtab), and (B10.D2 9 x NZB a'; Mtaa) were bred in our colony from breeding stocks from The Jackson Laboratory (Bar Harbor, ME). B10 .CAS2 (Mta"°ll) mice were bred in our colony from stocks provided by Dr. J. Klein, Tiibingen, FRG. MLC and CTL Clones.
As described previously (24, 37) , Fl mice were primed by intraperitoneal injection of 4 x 107 splenocytes from Mta-disparate reciprocal F1 male mice. After 3 wk, the spleen cells of the responding mice were cultured in supplemented MishellDutton medium (sMDM) for 3-6 d with y-irradiated (1,500 rad) splenocytes from the immunizing strain at a 6:1 responder-to-stimulator cell ratio . At the end of the initial culture, viable cells were plated at limiting dilution (1, 10, or 1,000 cells/well) in 96-well flat-bottomed culture plates with y-irradiated stimulator cells and an ammonium sulfate-purified supernatant from PMA-induced EL4 cells, containing 10 U/ml IL-2 (37). Cultures were fed weekly for 2-4 wk with fresh sMDM/IL-2 and stimulator cells (4-6 x 106 cells/ml) . Cultures from the microtiter wells were screened for their ability to lyse 5'Cr-labeled Con A blasts (CABs) from the stimulating strain . Positive wells were expanded to 24-well plates (Linbro, McLean, VA) and screened for specificity on "Cr-labeled CABs from Mta-disparate, reciprocal Fl strains. Cultures demonstrating MW specificity were maintained by weekly seeding 3 x 10 4 viable CTLs into 1.5 ml of fresh sMDM/IL-2 with irradiated stimulator cells (3-4 x 10 6 cells/ml) in a 24-well plate. Most of the lines were derived from limiting dilution cultures that were seeded at an average of 1 or 10 cells/ml, in which fewer than 20% of the wells were positive for cytotoxic activity.
Target Cells. Target cells were from the tumor cell lines EL4 (C57BL/6 thymoma, H-26, Mtaa) and WEHI-105 .7 (NZB thymoma, H-2 d, Mtab) or were lymphoblasts harvested 3-5 d after culture with Con A. CABs were generated as described by Smith et al . (38) by culturing 5 x 10' splenocytes/ml for 3-5 d in modified Mishell-Dutton medium (mMDM) with 2.5 wg/ml Con A (Pharmacia Fine Chemicals, Uppsala, Sweden). The tumor cell lines EL4 and WEHI-105 .7 were maintained in DME with 10% FCS. Target cells at 10 6 cells/ml in DME + 10 01o FCS were incubated for 12-15 h (except where indicated) with the appropriate peptide at a final peptide concentration of 400 nM and 0.5% DMSO (required because of the hydrophobicity of the peptides). The cells were centrifuged, labeled with 150 ttCi of "Cr for 60-75 min at 37 0C, and washed in cold HBSS containing 5% FCS. The labeled cells were enriched for viable cells by density gradient centrifugation over Isolymph (GallardSchelesinger Corp., Carle Place, NY). The cells were then washed twice and resuspended at 5 x 10 5/ml in assay medium (supplemented MEM, 10 01o FCS, and 50 Wg/ml gentamicin) .
Peptide Synthesis. Peptides in Table I were synthesized by solid-phase techniques on a peptide synthesizer (No. 430A ; Applied Biosystems, Inc., Foster City, CA) using the small scale rapid cycle chemistry programs from Applied Biosystems . t-Butyloxycarbonyl-(t-Boc) NCIprotected amino acids were coupled to the t-Boc amino acid-OCH2-phenylacetoamidomethylpolystyrene resin. All amino acids and loaded resins were purchased from Applied Biosystems except the formylated and acetylated methionine, formylated valine, and formylated phenylalanine which were from Bachem Bioscience Inc. (Philadelphia, PA). Peptides were cleaved from the resin and deprotected using trifluoroacetic acid-trifluoromethanesulfonic acid procedure (39) . After cleavage the peptides were precipitated and washed with anhydrous ether, dried, and solubilized in DMSO . Peptides were assayed for purity by reverse-phase HPLC and amino acid analysis (Pico Tag System ; Waters Associates, Milford, MA); several peptides were also analyzed by N112-terminal amino acid sequence analysis (477A Protein Sequencing System, Applied Biosystems, Foster City, CA).
Competition Experiments . WEHI-105 .7 cells at 106 cells/ml were incubated at 37°C with increasing concentrations of fMet6-a, AcMet6-a, Met6-a (peptides, IV, VI, and VIII ; Table  I ) or the chemotactic peptides N-formyl-Nle-Leu-Phe-Nle Tyr-Lys, N-formyl-Met-Leu-PhePhe, and N-formyl-Met-Leu-Phe ; or the chemotactic antagonist t-Boc-Met-Leu-Phe (Sigma Chemical Co., St . Louis, MO). After 4-10 h, a 20 nM concentration of fMet12-a (peptide II, Table I ) was added to each mixture and the cells were reincubated for another 4-10 h. Target cells were then labeled with "Cr, washed, and processed as above. CML Assay. As described previously (24) , long-term monoclonal CTLs were collected, washed once, and resuspended in assay medium . Viable CTLs (effector cells) were counted by fluorescein diacetate uptake . 100 pl of CTL suspension were added to 96-well roundbottomed culture plates (Costar, Cambridge, MA). Target cells at 0.5-1 .0 x 104 cells per well were plated at multiple effector-to-target cell ratios . After a 4-h incubation at 37'C, the supernatants were harvested using a supernatant collection system (Skatron, Sterling, VA). Spontaneous release (SR) was measured by incubating target cells in assay medium alone; maximal release (MR) was measured from target cells lysed by 1% SDS. Data are expressed as follows: percent specific lysis = [(experimental release -SR)/(MR -SR)] t SE . The standard error was estimated by propagation of errors. If no error bar is shown, the error was <5%.
Results
Exogenous NDI-ce Peptide Mimics Endogenous Mff" Peptide. To assess the possible role of the N-formyl group in Mta, we established conditions under which exoge- nous synthetic NDI peptides were presented appropriately to Hmt-restricted, Mtfspecific CTL. EL4 cells (Mtaa) or WEHI-105 .7 cells (Mtab) were incubated with a 400 nM concentration of fet6-cx or fMet26-a (peptides I and XI, Table I ) and tested for lysis by Mtab-specific or Mtaa-specific CTLs, respectively. As expected, polyclonal Mtab-specific CTLs lysed Mtaa cells only when incubated with the fMet6-Q peptide, not when incubated with the fMetM-cx peptide ( Fig. 1 A) . Reciprocally, Mtaa-specific polyclonal CTL as well as 32/32 CTL clones (8 representative clones are shown) lysed Mtab target cells incubated with fMetM-a, but not with fet26-S (Fig . 1 , B and C) . In the specificity assay screened at a single effector-totarget cell ratio, a few Mtaa-specific clones did exhibit up to 20% lysis on targets pulsed with inappropriate peptide ( Fig. 1 C) ; this apparently inappropriate activity was not observed when Mtaa-specific CTL clones were expanded and assayed at multiple ratios. Additionally, neither cell line lost its native antigenic phenotype when incubated with the disparate peptide (data not shown) . NDI-a and 0 peptides mimic endogenous Mtfgene products a and 16. The indicated NDI peptides (fMet26-a or fMet26-0) were incubated with EL4 (Mtaa) or WEHI 105.7 (Mtab) target cells at a concentration of 400 nM in 0.5% DMSO final concentration . Incubation was for 12 h at 37°C before 51 Cr labeling. The cells were washed four times before inclusion in a 4-h 51 Cr-release assay. Control cells were similarly incubated in 0.5% DMSO alone. (A) Specific recognition of NDI-S (fMet26 -t$) peptide by polyclonal Mtab-specific CTLs . Polyclonal CTL were generated by immunizing Mtaa (B10 .D2 9 x NZB a") F1 mice with NZB (Mtab) spleen cells. antigen-specific cell-mediated cytolysis, peptide recognition should also be Hmt restricted. We tested this hypothesis using CABs from B10.CAS2 mice, which carry the functionally null Hmtb allele . B10.CAS2 splenocytes are resistant to lysis by Mtaa-specific CTLs even though these mice express endogenous Mtr (20, 21) .
Preincubation of Hmt°but not Hmtd CABs with a 400 nM concentration of either fMet26-a or fMet26-(3 (peptides I and XI ; Table 1 ) induced susceptibility to lysis by Mtaa-specific CTLs . We conclude that NDl-a peptide recognition is Hmt restricted (Fig . 2) .
Hmt Can Restrict a Peptide as Short as Six Amino Acids. To define the minimal structure of the My" product recognized by Mtaa-specific CTLs, a set of four peptides of decreasing length were synthesized (peptides fMet26-a, fet12-a, fet8-a, and fMet6-ac; Table 1 ) . Using these peptides, which differed only in length at their COOHtermini, we observed that polyclonal CTLs lysed target cells pulsed wtih fMet26-a and fet12-a peptides much more efficiently than they did targets incubated with fMet8-a (Fig . 3 A) . No lysis was observed when the fMet6-a was used (Fig . 3 A . In contrast, all 32 Mtaa-specific CTL clones recognized a-fMet8 as well, or nearly as well, as they did fMet26-a and fMet12-a . Surprisingly, 8 of 32 clones lysed Mtab targets pulsed with the shortest peptide tested, fMet6-a (e .g ., clones 1B3, 1GI1, and 3135 ; Fig. 3 B) . This exquisite discrimination was critical to competition experiments described below.
The Nformyl Group in NDI-a Peptides Is Requiredfor MY Mimicry. We proposed that Mtf peptides should have distinct biochemical properties to account for its selective restriction by Hmt. To test the hypothetical requirement for the N-formyl group in NDI peptides, two analogues of fet12-a were synthesized (peptides V and VII; Table I ), containing either nonsubstituted methionine (Met12-a) or N-acetylated methionine (AcMet12-a) at the NH2 terminus . Neither the nonsubstituted peptide nor the acetylated analogue induced recognition and lysis of Mtab target cells by Mtaa-specific CTLs . The requirement for the formyl group at the NH2 terminus of NDI-a was observed both with Mtaa-specific polyclonal CTL and with all 32 Mtaa-specific CTL clones (Fig . 4) . The Effect of Position 1 Methionine Variation on NDI-a Recognition. Because the Nformyl group of the initiator methionine was essential for Mtaa recognition, we reasoned that substituting methionine with other hydrophobic amino acids might interfere with Mta-specific immune recognition . To test this idea, two analogues were synthesized with formyl-phenylalanine (Whe12-a) or formyl-valine (Na112-a) at the same position (peptides IX and X; Table I ) . Using polyclonal Mtaa-specific CTLs, the specific lysis of targets incubated with equimolar concentrations of these analogues (Whe12-a and Na112-a) was reduced by 50-75%, as shown in Fig. 5 A . In contrast, most of the Mtaa-specific clones recognized the formylated analogs as efficiently or nearly as efficiently as they recognized fMet12-a (e.g ., clones IE3 and 1D3; Figure 5 B) ; however, some were less efficient (e.g ., clones 3D5 and 1C5) . Thus, although the NH2-terminal formyl group was absolutely required for the immune recognition of Mta, the identity of the NH2-terminal amino acid was not critical for 28/32 CTL clones . These findings suggested that the N-formyl amino acid interacts specifically with the antigen-presenting molecule, and that the M!f peptide interaction site on Hmt product may be an N-formyl-amino acid binder.
An N-Formyl-Peptide Receptor Is Requiredfor the Expression of Mta. The requirement for an N-formyl group at the NH2 terminus of the NDI peptide might reflect epitope discrimination by Mta-specific T cell receptors, binding by N-formyl peptide To determine the appropriate conditions for competition experiments, we established the time-course and dose-response required to transform WEHI-105 .7 cells (Mtab) into Mtaa-like targets. For the dose-response curve, WEHI-105 .7 cells were incubated for 12-14 h with concentrations of fet12-a ranging from 10 to 800 nM (peptide II, Table I ), and tested for lysis by Mtaa-specific CTL clones 1D3 and 1GIL As shown in Fig. 6 A, a concentration of fMet12-a peptide as low as 10 nM caused maximum target cell lysis. The time course was established by incubating WEHI-105.7 cells with a 400 nM concentration of fMet12-a for up to 18 h (51 Cr labeling included). 2 h or less were sufficient to cause maximum target lysis by Mtaa-specific clones (Fig. 6 B) .
We chose as a potential competitor the fet6-a peptide, which is antigenic for some Mtaa-specific CTL clones but not for others . WEHI-105 .7 cells (Mta b) were incubated with increasing concentrations of fet6-a, AcMet6-a, or Met6-a (peptides IV, VI, and VIII ; Table 1 ) for 4 h before the addition of a 20 nM concentration of fet12-a. Target cells were then incubated with Mtaa-specific clones that recognized fMet6-a (e.g ., 1G11 ; Fig. 7 B) , or did not recognize it (e.g ., 1D3; Fig. 7 A) . Inhibition of target cell lysis was observed with a concentration of fMet6-a peptide e lo 12 14 16 Preíncubatíon Time (h) as low as 1 AM (50-fold excess) and was maximal with 2 AM (100-fold excess) when clone 1133 was used as an effector. However, no effect was seen with a 1,000-fold excess of fet6-a peptide when clone 1G11 was used . Significantly, no inhibition of target cell lysis was observed with either clone 1133 or 1G11 when AcMet6-a or Met6-a (peptides VI and VIII ; Table 1 ) were used as competitors. Our results demonstrate that a receptor critical to Mtf peptide presentation can be competitively occupied by fet6-a peptide, but not AcMet6-a or Met6-a peptides . The Nformyl-NDI Peptide Receptor Difersfrom the Chemotactic Peptide Receptor. To distinguish the Mta-associated N-formyl peptide receptor from the chemotactic peptide receptor, which also binds some N-formyl peptides, we attempted cross-competition experiments. If both receptors are the same, known chemotactic peptides should competitively inhibit the activity of Mtf peptides . We chose three potent chemotactic peptides : N-formyl-Nle-Leu-Phe-Nle-Tyr-Lys, N-formyl-Met-Leu-PhePhe, and N-formyl-Met-Leu-Phe ; and a chemotactic antagonist t-Boc-Met-Leu-Phe (40-42). As shown in Table II , all four peptides failed to inhibit target lysis (IC5o of »20 AM). In contrast, the IC5o of fet6-a was 41-3 AM. In addition, incubating WEHI-105 .7 cells with up to 20 AM of any of these chemotactic peptides did not render these cells susceptible to lysis by any Mta-specific CTLs (data not shown) . These results demonstrate that the Mta-associated N-formyl receptor is distinct from the chemotactic formyl-peptide receptor.
Discussion
Our results demonstrate a requirement for the N-formyl group of Mtf peptides for target cell recognition by Mta-specific CTLs . In addition, our competition experiments establish that a novel N-formyl peptide receptor expressed on APCs is required for Mta expression. Although we do not know the identity or the characteristics of this receptor, we can speculate on candidates. With the exclusion of the chemotactic receptor (43, 44) , there are at least two possible candidates for the Mtaassociated N-formyl receptor at the surface of the APC: the Hmt gene product, or TABLE 11 Ma-associated N-Formyt Peptide Receptor Is Distinct from the Chemotactic Receptor WEHI 105 .7 cells were incubated with increasing concentrations (0-20 ,UM) of the chemotactic peptides Nle-Leu-Phe-Nle-Tyr-Lys (CTP6), fet-Leu-Phe-Phe (fMLPP), fet-Leu-Phe (fMLP) ; the chemotactic peptide antagonist t-Boc-MetLeu-Phe (t-Boc-MLP); or fet6-a . Competition experiments were as described in Fig . 7 . The effector-to-target cell ratio was 4 :1 for Exp . 1 and 2 .5 :1 for Exp . 2 . The 50% inhibitory concentration (IC5o) was estimated from experiments in which fMet6-a peptide inhibited >50% of the maximum specific lysis .
Mtaa-Specific clone
Exp . fet6-a 50% CTP6 inhibitory concentration fMLPP fMLP t- Boc-MLP   14M   1133  1  <2  >20  >20  >20  >20  2  <1  >20  >20  >20  >20   1E3  1  <2  >20  >20  >20  >20  2  <4  >20  >20  >20  >20 an independent N-formyl receptor. We favor the former hypothesis as more parsimonious; it accounts at once for the selective restriction of Mtfpeptides by Hmt.
To account for the large hole in the H-2K/D/L repertoire that fails to restrict Mtf peptides, we propose that these antigen-presenting molecules are inefficient at presenting very hydrophobic molecules such as signal peptides . In contrast, the Hmt gene product should contain, in addition to the formyl-peptide binding site, a generally hydrophobic pocket . An independent N-formyl peptide receptor would have to be an intracellular processor that loads Mtfpeptides onto Hmt gene product. We would expect that such a protein processor would equally load onto H-2K/D/L antigenpresenting molecules. Although the Mta-associated N-formyl receptor is on the APC and may be the class I molecule itself, we can not exclude the possibility that the N-formyl group is also recognized by the TCR on the effector cells.
The function of N-formyl group at the NH2 terminus of Mtf peptide could be to neutralize the positive charge at the NH2 terminus of the peptide, but this argument is not supported by N-acetylation which did not restore the activity. The requirement for an N-formyl group has been demonstrated for all functional NDl-ac or -(3 peptides, irrespective of the peptide length or the first amino acid in these peptides (data not shown) . It is clear, however, that other structures in NDl peptides are also required, in that the N-formylated chemotactic peptides failed to compete for binding similar to fet6-a .
While the Mtaa-specific polyclonal CTLs did not recognize the six amino acid peptide from My, one-fourth of the long-term CTL clones (8/32) investigated recognized this peptide. In fact, this difference was critical to the competition experiments that established the N-formyl-NDI peptide receptor. The variation among CTL clones for recognition and lysis of target cells preincubated with ND1-ar peptides of decreasing lengths probably reflects expression of clonotypic T cell receptors. For example, for some cytochrome c-specific T cell clones changes limited to the junctional regions of the TCR sequences altered the specificity for the peptide without altering the MHC specificity (45, 46) . Our results on the minimal length of My' are compatible with those reported in the literature . Although generally ranging between 9 and 25 amino acids (2, 16) , the shortest T cell epitope reported is a pentapeptide from the immediate-early phase regulatory protein of murine cytomegalovirus (13) .
Although no direct physical evidence has been presented on binding of NDl peptides to the putative class I-like, Hmt product, the selective recognition of Hmta cells by the appropriate CTLs implies that Hmt product is the molecule involved in the interaction with the T cell antigen receptor. It is not understood how the Hmt product-exogenous MV peptide complex is constructed at the cell surface. Possible mechanisms include exchange of the exogenous Mtf peptides with the endogenous peptides at the cell surface; association of the exogenous peptide with unoccupied Hmt molecules at the cell surface; or internalization of Mtfpeptides and intracellular construction of the antigen.
NADH-dehydrogenase is a conserved mitochondrial enzyme composed of about 25 subunits, seven of which (ND1, 2, 3, 4, 4L, 5, and 6) are encoded by the mitochondrial genome (47, 48) . NDl is a remarkably hydrophobic, mitochondrial transmembrane protein of 35 kD (48) . It has been proposed that a hydrophobic leader sequence of 11 amino acids may be cleaved by a signal peptidase from Xenopus laevis ND1 after the protein is anchored in the mitochondrial membrane (49) . Whether this proposed leader sequence is the native Mtfepitope is still unknown. Although some of the mechanisms of protein import into mitochondria have been well studied (50) , the pathways of vectorial transport of mitochondrially encoded proteins are not fully understood (51) . However, for the native Mtf peptide to be presented at the cell surface it must be transported via a protein traffic pathway (52, 53) . We do not know how native Mtf peptides end up at the cell surface, but it should be possible to study this pathway using drugs that block transport of newly synthesized proteins (54, 55) .
The possibility that the Hmt gene product is a scavenger of hydrophobic Nformylmethionyl peptides derived from endogenous mitochondrial translation products has been proposed earlier (20) . Further studies will be required to determine whether the Hmt product binds Mtf peptides on the basis of hydrophobicity in addition to the N-formyl group or both . Whether the Mtfproduct is the only hydrophobic mitochondrial product transported by the Hmt product is not known. Comparing the hydrophobicity profile (56) of the first 20 amino acids from ND1 with the mitochondrial ORFs (47) suggests similar hydrophobic sequences at the NH2 terminus of ND2, ND4, and ND5 .
Finally, it is possible that a biological role of the N-formyl peptide receptor may be to select those intracellular peptides derived from organisms and organelles of prokaryotic origin, and present them at the cell surface to the immune system . If so, then the Hmt/N-formyl receptor system might represent an ancestral specialization involved in immune defenses against intracellular prokaryotic pathogens.
Summary
Maternally transmitted factor (MY) is a mitochondria) gene that controls the antigenic polymorphism of the MHC class I maternally transmitted antigen (Mta). Synthetic peptides from the NH2 terminus of the mitochondrially encoded NADH dehydrogenase subunit 1 (NDI) mimic Mtfpeptide activity in an allele-specific manner. We show that the minimal NDl-ct peptide length recognized by Mtaa-specific polyclonal CTLs was between 8 and 12 amino acids, while some Mtaa-specific CTL clones recognized a six amino acid peptide. The N-formyl group at the NH2 terminus of NDl was essential for Mta activity. Competition experiments using Nsubstituted ND1-a peptides showed that an N-formyl peptide receptor on the target cell, which differs from the chemotactic peptide receptor, was required for Mta expression . The specificity of this receptor can account for the distinct immune restriction of Mta in which Mtfpeptides are uniquely restricted by Hint . It is possible that the Hmt gene product is the N-formyl peptide receptor itself and that it represents a class I antigen presentation molecule specialized for binding, transport, and immune presentation of N-formyl-peptide antigens of mitochondria) and prokaryotic origin .
